Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Barchart

Unusual Call Option Volume in Corning Stock Highlights Its Value

Today, a large volume of in-the-money (ITM) call options in Corning Inc. stock traded, highlighting its underlying value. The optic fiber company has attracted value investors with its strong free cash flow results.

Barchart

National Fuel Gas - Growth and Divdend

Summary National Fuel Gas Company (NFG) shows strong technical buy signals, gaining 21.97% since Trend Seeker's buy signal on 1/13, with consistent price appreciation. NFG operates in four segments: Exploration and Production, Pipeline and Storage, Gathering, and Utility, providing diversified energy services in Pennsylvania and New York. Barchart's technical indicators...

Barchart

National Fuel Gas - Growth and Dividend

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

How to Play PepsiCo's Expected 5% Dividend Hike Next Month

PepsiCo has said it will hike its dividend by 5% but has not yet set the exact dividend per share amount - expected next month. One way to play this is to short out-of-the-money puts and buy long-dated calls.

Barchart

Top 10 Stocks to Buy: Xpeng Enters the Top 20. Is It Too Late to Buy?

Chinese EV manufacturer Xpeng moved up six spots in Monday trading to jump into the top 20 of Barchart’s Top 100 Stocks to Buy. Up 150% over the past year, it might be too late to buy.

Barchart

Banco de Chile - Great South of the Border Investment

Summary Banco de Chile (BCH) has shown strong technical indicators, including a 20.60% gain since the Trend Seeker buy signal on 1/17 and a 21.16% gain over the past year. The bank operates in Retail, Wholesale, Treasury, and Subsidiaries segments, offering a wide range of financial services in Chile, with...

Barchart

LYFT Stock's Valuation Looks Too Cheap Based on Its FCF and Margins

Lyft generated $766 million in free cash flow (FCF) last year, or over 13% of its revenue. However, LYFT stock has a 15% FCF yield now - too high. Based on a conservative 10% FCF yield, LYFT could be worth at least 31.5% more.

Barchart

Read news from The Economist, FT, and more,
with one subscription

B2Gold (BTG) is Signaling Both Unusual Options Activity and the J-Hook

BTG stock attracting attention from the smart money is already a noteworthy development. Flashing the J-Hook adds the cherry on top.

Barchart

Gold Surges Past $3,000: A Historic Rally with Risks Traders Can't Ignore

Despite the bullish sentiment in the gold market, traders should remain cautious. Gold has been on a relentless upward trajectory since September 2022, leading some analysts to question whether the metal is already over-priced at these levels. As early investors look to cash in on profits, the risk of a…

Barchart

3 High-Yield Dividend Aristocrats Worth Buying To Survive a Recession

These three Dividend Aristocrats care about profitability, predictable dividend growth, and sustainable payout ratios for their income investors.

Barchart

Microsoft Stock May Have Bottomed - Shorting Puts May Be a Good Play

Microsoft may have bottomed, which could be a good entry point for value investors. Selling short out-of-the-money puts in nearby expiry periods sets a lower buy-in target and lets investors get paid while waiting.

Barchart

A Little-Known Gold Miner Just Flashed the Bullish J-Hook Signal

Amid a strengthening case for the fear trade, the precious metals complex potentially offers one of the rare avenues for robust capital gains.

Barchart

Gilead Sciences - Leader in HIV Medicines

Summary Gilead Sciences (GILD) shows strong technical buy signals, with a 19.60% gain since Trend Seeker's buy signal on 1/27 and a 50.31% gain in the last year. The company offers a diverse portfolio of medicines for HIV, COVID-19, liver diseases, oncology, and more, with significant collaborations enhancing its pipeline....

Barchart

Benitec - Another Biopharma Rocket

Summary Benitec Biopharma (BNTC) shows strong technical indicators with 100% buy signals, a 127.84+ Weighted Alpha, and a 190.67% gain in the last year. The stock is above its 20, 50, and 100-day moving averages, with 11 new highs and a 42.86% increase in the last month. Wall Street analysts...

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

These 3 Top 100 Stocks to Buy Jumped 10 Spots or More on Monday. Buy or Sell?

Monday trading continued the unwinding of gains post-Trump. The S&P 500 lost 2.7%, 130 basis points away from a correction. These three Barchart Top 100 Stocks to Buy jumped 10 spots or more yesterday.

Barchart

Xeris Biopharma - Possibly the best Pharma Stock

Summary Xeris Biopharmaceuticals has shown strong technical buy signals, with a 30.03% gain since the Trend Seeker buy signal on 1/28. The company offers innovative therapies like Gvoke, Keveyis, and Recorlev, and is developing XP-8121 and XeriSol/XeriJect technologies. Barchart indicators show 100% technical buy signals, a 95.32% gain in the...

Barchart

Occidental Petroleum is an Analyst Favorite - 2% Dividend Yield and Higher Price Targets

Occidental Petroleum's 9% dividend hike last month has made OXY stock an analyst favorite. It looks cheap based on their price targets. Shorting out-of-the-money puts can provide extra income and set a lower buy-in target price.

Barchart

Why Intuitive Machines’ (LUNR) Unusual Options Activity Could Be a False Signal

Although the cratering of LUNR stock due to an unexpected mission challenge seemingly offers a discount, investors should exercise extreme caution.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Orla is Golden

Summary Orla Mining (ORLA) shows strong technical buy signals, with a 101.60% gain in the last year and a Trend Seeker buy signal since 2/26. The company owns significant mining projects in Mexico, Panama, Nevada, and Canada, exploring for gold, silver, zinc, lead, and copper. Fundamental factors include a market...

Barchart

Another Insider Is Selling Palantir Stock. Should You?

Palantir’s explosive gains from strategic deals clash with hefty insider exits and market sell-offs amid escalating trade concerns

Barchart

ExxonMobil Stock Still Looks Cheap to Analysts - Short Put Plays Have High Yields

ExxonMobil stock is off its lows but still looks cheap to analysts. After all, XOM has a 3.6% annual dividend yield and a forward multiple below 13x earnings. Moreover, selling short out-of-the-money put options is a good income play.

Barchart

Embraer Is Flying High

Summary Embraer S.A. (ERJ) has shown a 35% gain since a Trend Seeker buy signal on 1/15, driven by strong technical indicators. The company operates in multiple segments including Commercial Aviation, Defense & Security, and Executive Aviation, with a global presence. Barchart's technical indicators show 100% buy signals, a 139.50%...

Barchart

LENSAR - Top Healthcare Equipment Stock

Summary LENSAR (LNSR) has shown strong technical buy signals, high Weighted Alpha, and consistent price appreciation, gaining 16.65% since the Trend Seeker buy signal on 2/28.. The company specializes in femtosecond laser systems for cataract treatment, with notable products like the LENSAR Laser System and ALLY Adaptive Cataract Treatment System.....

Barchart

Elbit Systems - Leader in Aerospace & Defense Solutions

The Chart of the Day belongs to the aerospace & defense company Elbit Systems (ESLT) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used...

Barchart

Chevron Stock's 4.5% Yield Attracts Value Investors, Along with Short-Put Plays

Chevron stock has an attractive 4.5% dividend yield after its recent dividend per share hike. This is attractive to value investors, who can also take advantage of this by selling short out-of-the-money put options for extra income.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.